Toward a better understanding of the brain
Genome-editing pioneer Feng Zhang hopes his work will shed light on neurological disorders.
Search Stories
Targeting cancer from many angles
Killian Award recipient Tyler Jacks fosters interdisciplinary, innovative cancer research.
Curing disease by repairing faulty genes
New delivery method boosts efficiency of CRISPR genome-editing system.
Faster drug discovery?
Startup develops more cost-effective test for assessing how cells respond to chemicals.
Mapping regulatory elements
Systematically searching DNA for regulatory elements indicates limits of previous thinking.
MIT, Broad scientists overcome key CRISPR-Cas9 genome editing hurdle
Team re-engineers system to dramatically cut down on editing errors; improvements advance future human applications.
New system for human genome editing has potential to increase power and precision of DNA engineering
CRISPR-Cpf1 offers simpler approach to editing DNA; technology could disrupt scientific and commercial landscape.
A metabolic master switch underlying human obesity
Researchers find pathway that controls metabolism by prompting fat cells to store or burn fat.
Identifying a key growth factor in cell proliferation
Researchers discover that aspartate is a limiter of cell proliferation.
Researchers develop basic computing elements for bacteria
Sensors, memory switches, and circuits can be encoded in a common gut bacterium.
3 Questions: Kenneth Oye on regulating drugs
New potential for “homemade” opiates raises oversight issues.
New evidence for how a rare form of liver cancer arises
MIT team finds mechanism by which exposure to vinyl chloride may produce cancerous mutations.
Taking technology from the lab to the patient
Daniel Anderson wants to bring advances in drug delivery and biomaterials to the clinic.
